UBS analyst Andrew Mok upgraded Universal Health to Neutral from Sell with a price target of $167, up from $113. The firm applied a defensive framework and assessed the strength and resiliency of companies’ financials and stock valuations as macroeconomic conditions may come under further pressure, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on UHS:
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
- Universal Health price target raised to $132 from $115 at Barclays
- Universal Health price target raised to $168 from $130 at Deutsche Bank
- Universal Health upgraded to Equal Weight on improved rates at Wells Fargo
- Universal Health upgraded to Equal Weight from Underweight at Wells Fargo
